Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays.
The objective of the present study was to determine the effects that hemolysis, lipemia, bilirubinemia, and anticoagulants might have on the most commonly used assays for C-reactive protein and serum amyloid A, and determination of ceruloplasmin values in dogs. Solutions of hemoglobin, lipid, and bilirubin were added to serum aliquots. Additionally, serum and plasma samples with different anticoagulants (heparin, EDTA, and citrate) were obtained from healthy dogs. Hemolysis, lipemia, and hyperbilirubinemia interfered significantly with the C-reactive protein and ceruloplasmin results, but not with those for the serum amyloid A assay. The use of anticoagulants produced significant changes in the results for the assays tested. However, the magnitude of the differences caused by the interfering substances does not appear to have an important impact on the clinical interpretation of the tests.
Martínez-Subiela
Silvi
S
Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, University of Murcia, 30100 Espinardo, Murcia, Spain.
Cerón
Jose J
JJ
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D002097:C-Reactive Protein / Q000378:metabolism*; D002570:Ceruloplasmin / Q000378:metabolism*; D004283:Dog Diseases / Q000097:blood / Q000175:diagnosis* / Q000378:metabolism; D004285:Dogs; D006461:Hemolysis; D006932:Hyperbilirubinemia / Q000097:blood / Q000175:diagnosis / Q000378:metabolism / Q000662:veterinary; D006949:Hyperlipidemias / Q000097:blood / Q000175:diagnosis / Q000378:metabolism / Q000662:veterinary; D066298:In Vitro Techniques; D000685:Serum Amyloid A Protein / Q000378:metabolism*
D000925:Anticoagulants; D000685:Serum Amyloid A Protein; D002097:C-Reactive Protein; D002570:Ceruloplasmin